Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities
- 23 March 2024
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 266 (Pt 1) , 131048
Abstract
No abstract availableKeywords
This publication has 237 references indexed in Scilit:
- Inhibiting astrocyte connexin‐43 hemichannels blocks radiation‐induced vesicular VEGF‐A release and blood–brain barrier dysfunctionGlia, 2023
- Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood–Brain BarrierSmall, 2023
- Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)Urolithiasis, 2023
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- Synthesis and Application of Low Molecular Weight PEI‐Based Copolymers for siRNA Delivery with Smart Polymer BlendsMacromolecular Bioscience, 2022
- Poly (beta‐amino ester) as an in vivo nanocarrier for therapeutic nucleic acidsBiotechnology and Bioengineering, 2022
- Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B through inducing G0/G1 arrest and targeting MMP‐2/‐9 expression and activityBioFactors, 2022
- Lipid‐based nucleic acid therapeutics with in vivo efficacyWIREs Nanomedicine and Nanobiotechnology, 2022
- Lipid‐Based Nanocarriers for The Treatment of GlioblastomaAdvanced NanoBiomed Research, 2020
- Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma TreatmentAdvanced Materials, 2020